As global demand for precision oncology grows, one challenge is becoming increasingly clear: reliable access to medical isotopes.

In this second episode of our webinar series, Dr Massey de los Reyes, Chief Scientific Officer, explains how IsoMedica is addressing the global shortage of radioisotopes and why building a scalable, secure supply chain is critical for the future of radiopharmaceuticals.

A Growing Radiopharmaceutical Market Facing Supply Constraints

Radiopharmaceuticals are among the fastest-growing therapeutic modalities in oncology, supporting around 40 million¹ procedures annually across approximately 10,000² hospitals worldwide and is predicted to be worth over USD$30,1 billion³ by 2028.

However, the supply of high-purity medical isotopes remains limited, creating challenges for companies developing targeted therapies.

IsoMedica was established with aims to develop a reliable, scalable, and sovereign isotope supply.

A Vertically Integrated Medical Isotope Supply Model

entX’s competitive advantage lies in its vertically integrated “Mines to Medicines” model, combining feedstock sourcing, novel purification technology, and advanced manufacturing to deliver a secure and scalable medical isotope supply chain.

Advanced Manufacturing for Radiopharmaceutical Supply

The Advanced Radioisotope Manufacturing Facility (ARMF) enables end-to-end isotope production through specialised infrastructure, automation, and regulatory systems, positioning entX as a key player in supporting a sovereign radiopharmaceutical supply chain in Australia.

In 2026, IsoMedica is transitioning from development to delivery, as entX brings production online, scales thorium-228 purification, supports lead-212 supply, and expands research, biotech and pharma partnerships.

Watch the full video above to learn how IsoMedica is helping secure the future of medical isotope supply and radiopharmaceutical innovation.

Catch up on Episode 1, featuring Managing Director, Bryn Jones.

1.International Atomic Energy Agency 

2.World Nuclear Association

3.Market Data Forecast